Potent and synergistic neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by hyperimmune anti-HIV immunoglobulin combined with monoclonal antibodies 2F5 and 2G12.

類似資料

• Neutralizing Monoclonal Antibodies Block Human Immunodeficiency Virus Type 1 Infection of Dendritic Cells and Transmission to T Cells
  著者:: Frankel, Sarah S., 等
  出版事項: (1998)
• Neutralizing Antibodies from the Sera of Human Immunodeficiency Virus Type 1-Infected Individuals Bind to Monomeric gp120 and Oligomeric gp140
  著者:: Stamatos, Nicholas M., 等
  出版事項: (1998)
• Anti-SARS-CoV-2 hyperimmune immunoglobulins, an urgent strategic choice
  出版事項: (2020)
• Protection of Macaques against Pathogenic Simian/Human Immunodeficiency Virus 89.6PD by Passive Transfer of Neutralizing Antibodies
  著者:: Mascola, John R., 等
  出版事項: (1999)
• Salivary human immunodeficiency virus (HIV)-1-specific immunoglobulin A in HIV-1-exposed infants in Kenya
  著者:: Farquhar, C, 等
  出版事項: (2008)